Wall Street is PANICKING Over These 3 Stocks! But Smart Money And I Are Betting Everything On These

Imagine a company telling investors that demand is so strong that its products are completely sold out through early 2029. Management says it cannot satisfy nearly 70% of demand next year. Customers are already reserving capacity for 2030. And yet, its share price has fallen approximately 25% in only five trading days. If that sounds irrational, welcome to the current stock market. Now, consider another company positioned at the center of AI infrastructure. Its AI-related revenue more than doubled during 2026. Management expects that revenue to double again in 2027 and then double once more in 2028. The company is not struggling to find customers. Management has clearly stated that it remains supply-constrained, not demand-constrained. In simple terms, it could potentially sell even more AI products if sufficient manufacturing capacity were available. Yet, its stock is down approximately 36% from its 52-week high. This is precisely the kind of environment that created Warren Buffett's famous investing principle: Be fearful when others are greedy and greedy when others are fearful. Another quotation commonly attributed to Baron Rothschild expresses the same idea more dramatically: The time to buy is when there is blood in the streets. Neither statement means investors should blindly purchase every falling stock. A declining share price cannot rescue a deteriorating business. The real opportunity appears when fear pushes down the valuation of a company whose revenue, earnings, customer orders, and long-term competitive position remain strong. That is exactly what appears to be happening beneath the surface of today's market. The S&P 500 remains only 2% below its record high, but approximately 84% of its companies are trading at least 10% below their individual all-time highs. The index looks healthy because a small group of enormous companies is holding it up while most stocks are already experiencing a meaningful correction. At the beginning of 2026, markets expected the Federal Reserve to cut interest rate three times. Instead, the Fed has already increased rates once and investors now expect three additional increases by June 2027. Oil above 100 and renewed inflation concerns have intensified the pressure. But interest rates do not cancel confirmed customer orders. They do not create additional manufacturing capacity, eliminate data center bottlenecks, or reduce the computing requirements of AI agents. The question investors must ask is simple. Are these share prices falling because the business are deteriorating or because the market is temporarily repricing fear? When customers are doubling AI revenue, selling capacity years in advance, and turning away customers while their share prices collapse, I do not automatically see danger. I see the kind of fear that can create exceptional long-term buying opportunity. The Kobacy Letter believes the same backdrop could eventually produce a powerful market reversal. Its analyst wrote, "This backdrop has the ability to catalyze a violent rally in the S&P 500 if and when it is ultimately priced out. If interest rate fears begin to ease and market participation broadens beyond the small group of companies currently supporting the index, buying pressure could return quickly. By the time the economic headlines improve and investors feel comfortable buying again, many of today's discounted prices may already have disappeared. The number one stock to buy in this dip is Broadcom. Broadcom's biggest problem is unusual. Customers want to buy more AI chips than the company can supply. That completely changes how I view the recent 36% decline. This is not a business desperately searching for growth. Management expects approximately 58 billion in AI revenue during fiscal 2026, more than double the previous year. Broadcom has already secured enough manufacturing capacity to target 115 billion in 2027, but even that will not satisfy current demand. Then comes the number that sounds almost unrealistic. Management sees a path toward approximately 230 billion in AI semiconductor revenue during 2028. That would mean doubling in 2027 and doubling again in 2028. These forecasts are not supported by PowerPoint slides alone. Quarterly revenue has already risen approximately 86%. Adjusted earnings have increased 96% and free cash flow has expanded by more than 80%. Broadcom is converting AI demand into actual cash at an extraordinary rate. At roughly $329 per share, the stock trades nearly 30 times forward earnings. That is not conveniently cheap, but conventional valuation becomes less useful when earnings are potentially doubling. Its forward [snorts] PEG ratio of approximately 0.56 suggests investors are paying surprisingly little for each unit of expected growth. However, there is a small catch. Broadcom depends heavily on a few enormous AI customers and may carry indirect financial exposure through arrangements used to finance their chips and data centers. If those customers encounter funding problems, Broadcom could feel the impact, but that is a future risk. Today's evidence shows rising revenue, expanding cash flow, and demand exceeding supply. The market is pricing Broadcom like its growth story is already breaking. However, management is describing a business struggling to manufacture products fast enough. Both views cannot remain correct forever. I view Lumentum as a undervalued buy the dip opportunity. Second stock on today's list is Lumentum and its recent sell-off makes little sense unless investors believe the entire AI infrastructure expansion is about to stall. Picture the conversation inside its factories. Customers are not asking for discounts or reducing orders. They are trying to reserve products that Lumentum cannot manufacture fast enough. Its optical components are reportedly sold out through early 2029 while some customers are already discussing 2030 capacity. For certain products, the company cannot satisfy nearly 70% of next year's demand. Why are these components so important? AI clusters contain thousands of processors that must constantly exchange data. Copper connections eventually encounter speed, distance, and power limitations forcing data centers toward optical technology. Lumentum provides the lasers and photonic components enabling that transition. Revenue is already growing approximately 83% year over year. Fiscal 2027 growth could reach around 70% while current Wall Street expectation suggests sales could potentially double. This is no longer merely an attractive future market. The capacity shortage is happening now. The next chapter is cash generation. Lumentum holds approximately 1.1 billion in net cash giving it room to expand without immediately depending on outside financing. The valuation is demanding at roughly 40 times forward earnings and approximately 59 times estimated forward free cash flow. Execution must therefore remain exceptional. Two customers represent nearly 40% of revenue creating genuine concentration risk. Investors should also expect growth to moderate as comparisons become tougher. But a 25% decline in 5 days has reset expectation. The market sees an expensive stock. I see a capacity constrained supplier whose customers are competing for products years before delivery. Third stock on today's list is Micron. Micron's share price is telling one story. Its financial statements are telling another. The stock has fallen more than 11% this week as investors react to China's CXMT announcing progress on a denser DRAM architecture. But, CXMT has not disclosed production capacity, performance, customers, or commercial yields. Our proposed design is being valued like a finished product already shipping at scale. Micron, meanwhile, has just reported record annual revenue of approximately 133 billion and nearly 85 billion in net income. Its latest quarter generated a company record 54.2 billion in revenue, and management is guiding the next quarter above 60 billion. The business has not peaked yet. More importantly, Micron has secured approximately 134 billion in strategic customer agreements containing pricing floors. Around 25% of those obligations should be recognized within 12 months. Most of its 2027 HBM supply is already committed at significantly higher prices, while HBM 4 shipments are ramping for Nvidia's next-generation platforms. At approximately 879 per share, Micron trades near five times forward earnings. That valuation already assumes today's exceptional profitability will eventually decline. The real risk is not Chinese laboratory announcements. It is hyperscalers reducing capital expenditure and weakening memory demand. That possibility cannot be dismissed, but contracts, price floors, and accelerating HBM shipments provide more tangible evidence than an uncommercialized architecture. The market is pricing Micron like the downturn has begun, while management is still guiding toward another record quarter.